Antibody drug conjugates and bispecifics seize the spotlight at ASCO 2022
Clarivate
JUNE 23, 2022
As part of our Drugs to Watch series, our team of oncology experts pored over thousands of abstracts for presentations at this year’s just-concluded American Society of Clinical Oncology (ASCO) Annual Meeting. This signifies the growth potential of marketed drugs in established marketplaces and the complexity of oncology treatment paradigms.
Let's personalize your content